top of page

Next Generation CNS and Neuromuscular Therapeutics

Delivery of therapeutics to neural and muscle cells remains a major challenge in treating neurological diseases

Global CNS Biodistribution

Our IV delivered carrier peptides enable systemic distribution to the deepest regions of brain tissue

Intracellular delivery

Our carrier peptides can deliver intracellularly and hit intraneuronal targets

Specificity

Hits intracellular and extracellular targets specifically

Endosomal escape

Our carrier peptides are engineered to efficiently distribute into the brain parenchyma

Stability

Our carrier peptides are highly modular and stable in a variety of conformations

Safety

Highly specific gene targeting, reducing risk of off-target effects

The NPT Platform is modular and stable with diverse cargos

Centron Bio is using proprietary Neuro-penetrant Peptide (NPT-1 and NPT-2) platforms to systemically deliver a pipeline of novel therapeutics to the central nervous system​​

​

  • IV delivered CNS therapeutics

    • Delivering diverse cargo formats efficiently across the blood brain barrier​

​

  • Homogenous CNS biodistribution

    • Delivering therapeutics into deep brain regions​

​

  • Intra-neural delivery

    • High endosomal escape to reach intracellular targets in neural cells​

bottom of page